| | Amgen Inc on Tuesday reported a 4% increase in third-quarter revenue as the impact of the COVID-19 pandemic on drug prescriptions began to ease, but said prices for some of its drugs remained under pressure from lower-cost competition. | | | The United States has administered 423,942,794 doses of COVID-19 vaccines in the country as of Tuesday morning and distributed 521,502,845 doses, the U.S. Centers for Disease Control and Prevention said. | | | Pfizer Inc on Tuesday said it expected 2021 sales of the COVID-19 vaccine it developed with German partner BioNTech SE to reach $36 billion and forecast another $29 billion from the shot in 2022, topping analyst estimates for both years. | | | Unvaccinated Greeks will need to show a negative COVID-19 test to access state services, banks, restaurants and retail shops as cases hit a new daily record on Tuesday, health authorities said. | | | As the resurgent COVID-19 pandemic burns through the rural U.S. state of Idaho, health officials say they don't have enough tests to track the disease's spread or sufficient medical workers to help the sick. | | | Eli Lilly has retracted a request for European Union approval of its antibody-based treatment for COVID-19, citing a lack of demand from EU member states as the bloc focuses on other suppliers. | | | The Netherlands' Health Council on Tuesday recommended that adults aged 60 and older who have been previously been vaccinated against COVID-19 also receive booster shots. | | | AstraZeneca Plc provided Thailand 10.5 million doses of its COVID-19 vaccine last month, the firm said on Tuesday, months after an official said the government was considering curbing exports from its local plant because of lower supplies. | | | Mariano Quisto, a remote community leader in Peru's dense Amazon rainforest, first learned of the global pandemic in October when health workers arrived by boat at his isolated village with vaccines. | | | Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are meeting on Tuesday to consider how broadly Pfizer and BioNTech's COVID-19 vaccine should be rolled out among children ages 5 to 11, with shots potentially going into young arms as soon as Wednesday. | | | | |